일회용 프리필드 시린지 시장 : 규모, 점유율 및 동향 분석 보고서 - 재료별, 용도별, 유통 채널별, 지역별, 부문 예측(2025-2030년)

Disposable Prefilled Syringes Market Trends:

The global disposable prefilled syringes market size was valued at USD 7.3 billion in 2024 and is projected to grow at a CAGR of 13.7% from 2025 to 2030. This growth is driven by increasing demand for biologics, rising prevalence of chronic diseases, and the growing preference for self-administered injectable drugs. Prefilled syringes enhance patient safety, reduce contamination risks, and improve dosage accuracy, further fueling market expansion. Additionally, advancements in syringe materials, such as glass and polymer-based options, are improving product durability and usability. Expanding healthcare infrastructure and regulatory approvals for biologic therapies will further support market growth.

A significant driver of this market expansion is the escalating demand for biologic drugs, which often require precise and stable delivery systems. Biologics, including monoclonal antibodies used in the treatment of autoimmune diseases and cancers, are frequently administered via injection. For instance, AbbVie's Humira (adalimumab), a leading biologic for conditions such as rheumatoid arthritis and Crohn's disease, is available in prefilled syringe formats to ensure accurate dosing and enhance patient convenience. Similarly, Roche's Actemra (tocilizumab), used for rheumatoid arthritis and certain COVID-19-related complications, is offered in prefilled syringes to facilitate ease of administration.

The rising prevalence of chronic diseases, notably diabetes, further propels the market. According to the International Diabetes Federation, approximately 537 million adults aged 20 to 79 were living with diabetes in 2021, underscoring the need for efficient and reliable insulin delivery methods. Prefilled insulin syringes provide a safer and more convenient alternative to traditional vial-and-syringe approaches, reducing the risk of dosing errors and enhancing patient compliance.

Another contributing factor is the growing trend toward self-administration of injectable medications. Patients managing chronic conditions, such as multiple sclerosis and diabetes, increasingly prefer prefilled syringes for home use, minimizing the necessity for frequent healthcare facility visits. This shift is supported by the development of user-friendly syringe designs equipped with integrated safety features. For example, Sanofi's Dupixent (dupilumab), prescribed for atopic dermatitis and asthma, is available in prefilled syringes, enabling patients to self-administer their treatments effectively.

The COVID-19 pandemic has also influenced the adoption of disposable prefilled syringes, particularly in vaccination efforts. Vaccines developed by companies like Moderna and Pfizer-BioNTech have been distributed using prefilled syringes to ensure precise dosing and reduce contamination risks, highlighting the importance of such delivery systems in large-scale immunization programs.

Technological advancements in syringe materials and manufacturing processes are enhancing product safety and compatibility, especially with complex biologics. Prefilled syringes are now available in both glass and polymer formats, with polymer syringes gaining popularity due to their break resistance and reduced interaction with sensitive drugs. Leading companies like Becton, Dickinson and Company (BD) and Gerresheimer are at the forefront of innovating syringe design and production, focusing on improving drug stability and patient safety.

Global Disposable Prefilled Syringes Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global disposable prefilled syringes market report on the basis of material, application, distribution channel, and region:

• Material Outlook (Revenue, USD Million; 2018 - 2030)
• Glass Syringes
• Plastic Syringes
• Application Outlook (Revenue, USD Million; 2018 - 2030)
• Vaccines & immunizations
• Anaphylaxis
• Rheumatoid Arthritis
• Diabetes
• Autoimmune diseases
• Oncology
• Others
• Distribution Channel Outlook (Revenue, USD Million; 2018 - 2030)
• Hospitals
• Retail Pharmacies
• Online Pharmacies
• Region Outlook (Revenue, USD Million; 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Material
  • 1.2.2. Application
  • 1.2.3. Distribution Channel
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Material outlook
  • 2.2.2. Application outlook
  • 2.2.3. Distribution Channel outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Disposable Prefilled Syringes Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Disposable Prefilled Syringes Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Disposable Prefilled Syringes Market: Material Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Disposable Prefilled Syringes Market: Material Movement Analysis
• 4.3. Disposable Prefilled Syringes Market by Material Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Glass Syringes
  • 4.5.1. Glass Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Plastic Syringes
  • 4.6.1. Plastic Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Disposable Prefilled Syringes Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Disposable Prefilled Syringes Market: Application Movement Analysis
• 5.3. Disposable Prefilled Syringes Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Vaccines and immunizations
  • 5.5.1. Vaccines and immunizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Anaphylaxis
  • 5.6.1. Anaphylaxis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Rheumatoid Arthritis
  • 5.7.1. Rheumatoid Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Diabetes
  • 5.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Autoimmune diseases
  • 5.9.1. Autoimmune diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.10. Oncology
  • 5.10.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.11. Others
  • 5.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Disposable Prefilled Syringes Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Disposable Prefilled Syringes Market: Distribution Channel Movement Analysis
• 6.3. Disposable Prefilled Syringes Market by Ens-use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Retail Pharmacies
  • 6.6.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Online Pharmacies
  • 6.7.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Disposable Prefilled Syringes Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Disposable Prefilled Syringes Market movement analysis
• 7.3. Disposable Prefilled Syringes Market: Regional Estimates & Trend Analysis by Technology & Application
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. UK Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. Germany Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. France
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement scenario
    • 7.5.9.5. France Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1. Key Country Dynamics
    • 7.5.10.2. Competitive Scenario
    • 7.5.10.3. Regulatory Framework
    • 7.5.10.4. Reimbursement scenario
    • 7.5.10.5. Italy Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1. Key Country Dynamics
    • 7.5.11.2. Competitive Scenario
    • 7.5.11.3. Regulatory Framework
    • 7.5.11.4. Reimbursement scenario
    • 7.5.11.5. Spain Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1. Key Country Dynamics
    • 7.5.12.2. Competitive Scenario
    • 7.5.12.3. Regulatory Framework
    • 7.5.12.4. Reimbursement scenario
    • 7.5.12.5. Denmark Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.13. Sweden
    • 7.5.13.1. Key Country Dynamics
    • 7.5.13.2. Competitive Scenario
    • 7.5.13.3. Regulatory Framework
    • 7.5.13.4. Reimbursement scenario
    • 7.5.13.5. Sweden Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1. Key Country Dynamics
    • 7.5.14.2. Competitive Scenario
    • 7.5.14.3. Regulatory Framework
    • 7.5.14.4. Reimbursement scenario
    • 7.5.14.5. Norway Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Japan Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. China Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. India Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Australia Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Thailand Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Brazil Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Argentina Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. South Africa Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Saudi Arabia Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. UAE Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Kuwait Disposable Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Becton, Dickinson and Company (BD)
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Material benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Gerresheimer AG
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Material benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. SCHOTT AG
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Material benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. West Pharmaceutical Services, Inc.
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Material benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Medtronic
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Material benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Roche Holding AG
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Material benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Fresenius Kabi AG
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Material benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. SteriPack
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Material benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Ypsomed AG
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Material benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Meda Pharmaceuticals
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Material benchmarking
    • 8.2.10.4. Strategic initiatives